Colostrum Research: Alzheimer’s Disease
Explore peer-reviewed findings on how colostrum-derived proline-rich polypeptides (PRP), often referred to as Colostrinin, may influence neurodegenerative processes linked to Alzheimer’s disease. The summaries below highlight immune regulation, neuroprotection, and inflammatory pathways studied in laboratory and clinical settings.
Email Us Phone 800-308-4264
Study Summaries
Colostral Proline-Rich Polypeptides: Immunoregulatory Properties and Therapeutic Prospects in Alzheimer’s Disease
Published in Current Alzheimer Research (2009), this review describes PRP/Colostrinin as a peptide complex first isolated from ovine colostrum. It reports immunoregulatory effects on thymocyte maturation, humoral and cellular immune responses, and cytokine induction, along with the ability to limit reactive oxygen species and nitric oxide overproduction. The authors note psychotropic benefits, improved cognitive activity and behavior in old rats, humans, and chickens, and prevention of amyloid-beta aggregation as well as disruption of existing aggregates. A nonapeptide component showed similar properties, and PRP was found to modulate neurite outgrowth, suppress uncontrolled cell activation, reduce 4-HNE-mediated cellular damage, and influence cellular redox regulation, proliferation, and differentiation.
Colostrinin’s Protective Effects Against Alzheimer’s Disease via Prevention of Apoptosis in Human Neurones
This study in the Journal of Nutrition, Health & Aging (2009) examined whether ovine Colostrinin protects neuronal cells from synthetic beta-amyloid toxicity. Using cytotoxicity assays (MTT and LDH), researchers found that pre-treating human neuronal SHSY-5Y cells with 5 µg/ml CLN for 24 hours conferred neuroprotection against Abeta-induced neurotoxicity and reduced Abeta 1-40-induced apoptosis. The protection was diminished by the Fas ligand binding antibody Nok1, suggesting involvement of a Fas:soluble FasL interaction. The authors conclude that CLN could potentially play a role in preventing Alzheimer’s pathogenesis through inhibition of Fas-mediated apoptosis.
PRP Modulation of H2O2 and Cytokine Induction in Human Leukocytes
This paper from the Institute of Immunology and Experimental Therapy in Wroclaw, Poland, investigated PRP’s effects on human peripheral blood mononuclear cells stimulated by proinflammatory activators. PRP and its nonapeptide fragment inhibited 40–60% of PMA-induced H2O2 production and also inhibited superoxide dismutase activity. The two peptide preparations showed differing cytokine effects: NP induced TNF-α only, while PRP induced IL-6, IL-10, and TNF-α. PRP inhibited LP-induced release of TNF-α and IL-10, whereas NP inhibited IFN-γ and IL-10 release. The results suggest PRP may influence both adaptive and innate immunity and help regulate inflammatory mediators, offering insight into its reported benefits in Alzheimer’s patients.
Research by Category
Explore Synertek Colostrum
Learn more about the source, processing, and quality standards behind our colostrum products, or browse the full range of research topics.
Nature’s First Dietary Supplement – Colostrum. Copyright 2008, Synertek Colostrum. All Rights Reserved.
